Nuvalent, Inc.
USD123.51
-0.00 (-0.00%)
CEO
James R. Porter
IPO Date
2021-07-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$123.52
Prev. Close
$123.51
Day Low
$123.47
Day High
$123.56
52W Low
$71.13
52W High
$123.69
Market Cap
$9.09B
Volume
0.51M
| 3,444 |
| $0.00 |
| 18 Jun 2026 | Srivastava Sapna | director | A-Award | Acquired | 3,444 | $0.00 |
| 18 Jun 2026 | Squarer Ron | director | A-Award | Acquired | 3,444 | $0.00 |
| 18 Jun 2026 | Protopapas Anna | director | A-Award | Acquired | 3,444 | $0.00 |
| 18 Jun 2026 | Oliger Christy J. | director | A-Award | Acquired | 3,444 | $0.00 |
| 18 Jun 2026 | Meyers Michael L. | director | A-Award | Acquired | 3,444 | $0.00 |
| 18 Jun 2026 | Bogle Grant C. | director | A-Award | Acquired | 3,444 | $0.00 |
| 11 Jun 2026 | Noci Darlene | Chief Development Officer | M-Exempt | Acquired | 10,000 | $1.08 |
| 11 Jun 2026 | Noci Darlene | Chief Development Officer | M-Exempt | Acquired | 685 | $6.89 |